本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bicara Therapeutics

17.34
+0.01000.06%
盘后:17.33-0.0100-0.06%18:15 EDT
成交量:126.73万
成交额:2,197.67万
市值:11.47亿
市盈率:-5.58
高:17.61
开:17.29
低:17.01
收:17.33
52周最高:30.99
52周最低:13.70
股本:6,617.29万
流通股本:3,676.23万
量比:1.40
换手率:3.45%
股息:- -
股息率:- -
每股收益(TTM):-3.1097
每股收益(LYR):-2.5230
净资产收益率:-41.01%
总资产收益率:-26.14%
市净率:2.45
市盈率(LYR):-6.87

数据加载中...

2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/02/19

重要事件披露

Form 8-K - Current report